| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/23/2005 | EP1507520A1 Combination of selected opioids with other active substances for use in the therapy of urinary incontinence |
| 02/23/2005 | EP1507519A1 Medicament with delayed release of the active substance, containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol |
| 02/23/2005 | EP1507518A1 Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 02/23/2005 | EP1507515A2 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 02/23/2005 | EP1507514A2 Controlled release compositions of estradiol metabolites |
| 02/23/2005 | EP1507513A1 Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol |
| 02/23/2005 | EP1507455A1 Antimicrobial envelopes |
| 02/23/2005 | EP1414386A4 Canine cardiac diet |
| 02/23/2005 | EP1395583B1 New phenylpiperazines |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP1313489B1 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
| 02/23/2005 | EP1261606B1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 02/23/2005 | EP1226128B1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 02/23/2005 | EP1207757B1 Ectoparasiticidal aqueous suspension formulations of spinosyns |
| 02/23/2005 | EP1177177B1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/23/2005 | EP1175224B1 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy |
| 02/23/2005 | EP1133497B1 Crystal modification b of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluoro-1,4- dihydro-4- oxo-3-quinoline carboxylic acid |
| 02/23/2005 | EP1133482B1 Il-5 inhibiting 6-azauracil derivatives |
| 02/23/2005 | EP1119350B1 Rar antagonists as male anti-fertility agents |
| 02/23/2005 | EP1107962B1 Quinolin-2-one derivatives useful as anticancer agents |
| 02/23/2005 | EP1066304B1 Macrolide lhrh antagonists |
| 02/23/2005 | EP1058544B1 Inhibition of tnf activity with compositions comprising heparin and soluble tnf recpetors |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | EP1035870B1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 02/23/2005 | EP1017381B1 Butyrate derivatives in the treatment of fibromyalgia and chronic fatigue syndrome |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | EP0854709B2 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 02/23/2005 | EP0689454B2 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 02/23/2005 | CN1585818A Decontamination of surfaces contaminated with prion-infected material with oxidizing agent-based formulations |
| 02/23/2005 | CN1585817A Decontamination of surfaces contaminated with prion-infected material with gagseous oxidizing agents |
| 02/23/2005 | CN1585816A Foamable antimicrobial formulation |
| 02/23/2005 | CN1585777A 肝脏x受体激动剂 Liver x receptor agonist |
| 02/23/2005 | CN1585775A 6-O-acyl ketolide derivatives of erythromycine useful as antibacterials |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585771A Polycyclic guanine derivative phosphodiesterase V inhibitors |
| 02/23/2005 | CN1585770A Reverse-turn mimetics and method relating thereto |
| 02/23/2005 | CN1585769A A2b adenosine receptor antagonists |
| 02/23/2005 | CN1585768A Pyrazole derivatives as psychopharmaceuticals |
| 02/23/2005 | CN1585767A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585766A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585765A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585764A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585762A Pyridine derivatives as NMDA receptor ligands |
| 02/23/2005 | CN1585756A Substituted diphenyl heterocycles useful for treating HCV infection |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585754A Quinazoline derivatives as antitumor agents |
| 02/23/2005 | CN1585753A Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 02/23/2005 | CN1585751A 喹啉化合物 Quinoline compound |
| 02/23/2005 | CN1585750A Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585748A NK1 antagonists |
| 02/23/2005 | CN1585747A Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/23/2005 | CN1585744A Process for the preparation of benazepril |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1585647A Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases |
| 02/23/2005 | CN1585645A Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 02/23/2005 | CN1585644A Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 02/23/2005 | CN1585643A Benzotriazepines as gastrin and cholecystokinin receptor ligands |
| 02/23/2005 | CN1585642A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 02/23/2005 | CN1585641A Hydrazono-malonitriles |
| 02/23/2005 | CN1585640A N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 02/23/2005 | CN1585639A Antimalarial agents |
| 02/23/2005 | CN1585638A Linked biaryl compounds |
| 02/23/2005 | CN1585637A Enhancement of learning and memory and treatment of amnesia |
| 02/23/2005 | CN1585636A Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 02/23/2005 | CN1585635A 2-(4-isobutylphenyl) propionic acid medicinal composition |
| 02/23/2005 | CN1585634A Pharmaceutical composition comprising an adenosine A1/A2 agonist and a sodium hydrogen exchanger inhibitor |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/23/2005 | CN1585631A Process for preparing quick dissolving, high loading ribavirin compositions |
| 02/23/2005 | CN1585630A Method for the formation of ibuprofen crystals |
| 02/23/2005 | CN1585629A Carotenoid composition and method for protecting skin |
| 02/23/2005 | CN1585627A Microfabricated nanopore device for sustained release of therapeutic agent |
| 02/23/2005 | CN1585604A Compositions for appetite control and related methods |
| 02/23/2005 | CN1583803A Polysaccharose MF4 of mussel with enhancing immunity and anti-tumour activity |
| 02/23/2005 | CN1583800A Anti-tumor activating fuling scloerotium glucan sulfate and its preparation and use |
| 02/23/2005 | CN1583799A Extraction for radix cynanchi bungei polysaccharide and oral lozenge preparation |
| 02/23/2005 | CN1583783A Licorice acid double salt, preparing method and use thereof |
| 02/23/2005 | CN1583777A Long-noded pit viper dissolving fiber protein No.4 gene and use thereof |
| 02/23/2005 | CN1583773A Preparing method for raffinose calcium and use for raffinose as calcium-supplementing agent |
| 02/23/2005 | CN1583769A 9-[2-(phosphonomethoxy)ethyl] adenine bicycloalkoxide and its preparation |
| 02/23/2005 | CN1583758A Use of Maituolaicin |
| 02/23/2005 | CN1583753A Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics |
| 02/23/2005 | CN1583750A Use of 2-3-methylen-dioxy dibenzo [a, g] quinolizine onium chloride in treatment of diabete |
| 02/23/2005 | CN1583747A Pterin mononitrogen monoxide synthase inhibitor |
| 02/23/2005 | CN1583746A Methylamino-pterin derivative with inhibiting nitric oxide synthetase function |
| 02/23/2005 | CN1583745A Amino biological pterin derivative and pharmaceutical use thereof |
| 02/23/2005 | CN1583744A Pirenzepine organic acid salt and eye drops for treating myopia |
| 02/23/2005 | CN1583735A Enrichment of ligusticum lactone and its preparations |
| 02/23/2005 | CN1583728A Compound extracted from eucalyptus plant and use thereof |
| 02/23/2005 | CN1583710A Beta (3, 4-dihydroxyphenyl)-alpha-hydroxyisopropyl propionate and its synthesis |
| 02/23/2005 | CN1583175A Skin targeting medicinal composition and its preparation and use |
| 02/23/2005 | CN1583174A Long-term injection containing ethylcellulose and fatty acid ester |
| 02/23/2005 | CN1583095A Gingseng and ginkgo injection and its preparation |
| 02/23/2005 | CN1583043A Duyiwei extract and its preparation and use |
| 02/23/2005 | CN1583036A Composite panaxadiol and saponin with physiologic activity and its use and preparation |
| 02/23/2005 | CN1583004A Composition of cupresulflavone and its preparation |